Class IIITerminatedD-1449-2016
Drug recall · August 3, 2016
Divalproex Sodium Delayed-release Tablets USP recall
Why: Failed Tablet/Capsule Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.
- Lots / codes
Lot #: 02D163, Exp. 9/2017
- Quantity
- 14, 370 units
- Company
- Teva North America, Horsham, PA
- Distribution
- Nationwide and Puerto Rico
- Initiated
- May 18, 2016 · Voluntary: Firm initiated
- Classified
- July 27, 2016
- Reported
- August 3, 2016
- Ended
- January 17, 2017
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.